title: NSF prevention in clinical practice: summary of recommendations and guidelines in the United States, Canada, and Europe.
abstract: In this article we summarize recommendations and guidelines for the prevention of NSF from the United States, Canada, and Europe. J. Magn. Reson. Imaging 2009;30:1357-1363. (c) 2009 Wiley-Liss, Inc.
authors: Department of Radiology, Maastricht University Medical Center Maastricht, The Netherlands. timleiner@gmail.com
authors: Tim
authors: T
authors: Leiner
authors: Walter
authors: W
authors: Kucharczyk
mesh_terms: D002170:Canada; D003287:Contrast Media / Q000008:administration & dosage; D004305:Dose-Response Relationship, Drug; D005060:Europe; D005682:Gadolinium / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*; D054989:Nephrogenic Fibrosing Dermopathy / Q000139:chemically induced* / Q000517:prevention & control*; D017410:Practice Guidelines as Topic; D051437:Renal Insufficiency / Q000150:complications / Q000175:diagnosis*; D014481:United States
chemical_list: D003287:Contrast Media; D005682:Gadolinium